Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and appointments, here’s a quick look at which stocks will be in focus in today's trade:
Apollo Hospitals Enterprise, Lupin, Life Insurance Corporation of India, ABB India, Ola Electric Mobility, UPL, Zydus Lifesciences, Abbott India, Amber Enterprises India, Amara Raja Energy & Mobility, Aster DM Healthcare, Cholamandalam Investment and Finance Company, Crompton Greaves Consumer Electricals, Cummins India, Godrej Properties, Hexaware Technologies, Mankind Pharma, Multi Commodity Exchange of India, Saatvik Green Energy, and Smartworks Coworking Spaces will announce their quarterly earnings on November 6.
Grasim Industries Q2 (Standalone YoY)
Profit jumps 11.6% to Rs 804.6 crore Vs Rs 720.9 crore
Revenue soars 26% to Rs 9,610.3 crore Vs Rs 7,623.3 crore
One 97 Communications Paytm Q2 (Consolidated YoY)
Profit falls sharply to Rs 21 crore Vs Rs 928 crore
Revenue grows 24.2% to Rs 2,061 crore Vs Rs 1,659 crore
Exceptional loss at Rs 190 crore Vs exceptional gain of Rs 1,345 crore
Paytm partners with Groq to power real-time AI for payments and platform intelligence
InterGlobe Aviation Q2 (Consolidated)
Loss widens to Rs 2,582.1 crore Vs loss of Rs 986.7 crore
Revenue grows 9.3% to Rs 18,555.3 crore Vs Rs 16,969.6 crore
EBITDAR plunges 54.2% to Rs 1,114.3 crore Vs Rs 2,434 crore
EBITDAR margin drops to 6% Vs 14.3%
EBITDAR (excluding forex) zooms 42.5% to Rs 3,800.3 crore Vs Rs 2,666.8 crore
EBITDAR margin (excluding forex) expands to 20.5% Vs 15.7%
Britannia Industries Q2 (Consolidated YoY)
Profit zooms 23.1% to Rs 654.5 crore Vs Rs 531.5 crore
Revenue grows 3.7% to Rs 4,840.6 crore Vs Rs 4,667.6 crore
Board appoints Rakshit Hargave as an Additional Whole-Time Director and Chief Executive Officer of Britannia
Indian Hotels Company Q2 (Consolidated YoY)
Profit sinks 48.6% to Rs 284.9 crore Vs Rs 554.6 crore
Revenue rises 11.8% to Rs 2,040.9 crore Vs Rs 1,826.1 crore
Delhivery Q2 (Consolidated YoY)
Loss stands at Rs 50.4 crore Vs profit of Rs 10.2 crore
Revenue increases 16.9% to Rs 2,559.3 crore Vs Rs 2,189.7 crore
Vivek Pabari to take over as Chief Financial Officer of the company
Redington Q2 (Consolidated YoY)
Profit jumps 23.8% to Rs 350.2 crore Vs Rs 282.9 crore
Revenue soars 16.8% to Rs 29,075.6 crore Vs Rs 24,895.6 crore.
Godrej Agrovet Q2 (Consolidated YoY)
Profit falls 12% to Rs 84.3 crore Vs Rs 95.8 crore
Revenue increases 4.8% to Rs 2,567.4 crore Vs Rs 2,448.8 crore
International Gemmological Institute India Q2 (Consolidated YoY)
Profit grows 18.4% to Rs 129.8 crore Vs Rs 109.6 crore
Revenue jumps 21.4% to Rs 303.7 crore Vs Rs 250.1 crore
CSB Bank Q2 (YoY)
Profit increases 15.8% to Rs 160.3 crore Vs Rs 138.4 crore
Net interest income soars 15.3% to Rs 423.6 crore Vs Rs 367.5 crore
Provisions & contingencies zoom 357.6% to Rs 63.7 crore Vs Rs 13.9 crore
Gross NPA falls to 1.81% Vs 1.84% (QoQ)
Net NPA declines to 0.52% Vs 0.66% (QoQ)
Kaynes Technology India Q2 (Consolidated YoY)
Profit spikes 101.7% to Rs 121.4 crore Vs Rs 60.2 crore
Revenue zooms 58.4% to Rs 906.2 crore Vs Rs 572.1 crore
Chalet Hotels Q2 (Consolidated YoY)
Profit stands at Rs 154.8 crore Vs loss of Rs 138.5 crore
Revenue surges 95% to Rs 735.3 crore Vs Rs 377 crore
Berger Paints India Q2 (Consolidated YoY)
Profit falls 23.5% to Rs 206.4 crore Vs Rs 270 crore
Revenue rises 1.9% to Rs 2,827.5 crore Vs Rs 2,774.6 crore
TeamLease Services Q2 (Consolidated YoY)
Profit grows 12% to Rs 27.5 crore Vs Rs 24.6 crore
Revenue increases 8.4% to Rs 3,032 crore Vs Rs 2,796.8 crore
Deepak Fertilisers & Petrochemicals Corporation Q2 (Consolidated YoY)
Profit rises 1.5% to Rs 213.2 crore Vs Rs 210.1 crore
Revenue soars 9.4% to Rs 3,005.8 crore Vs Rs 2,746.7 crore
Motherson Sumi Wiring India Q2 (Consolidated YoY)
Profit jumps 8.7% to Rs 165.3 crore Vs Rs 152 crore
Revenue surges 18.8% to Rs 2,761.9 crore Vs Rs 2,325.6 crore
Apollo Micro Systems Q2 (Consolidated YoY)
Profit zooms 98.1% to Rs 31.1 crore Vs Rs 15.7 crore
Revenue surges 40.2% to Rs 225.3 crore Vs Rs 160.7 crore
Metropolis Healthcare Q2 (Consolidated YoY)
Profit grows 13.2% to Rs 52.7 crore Vs Rs 46.5 crore
Revenue increases 22.7% to Rs 429.2 crore Vs Rs 349.8 crore
Aditya Birla Fashion and Retail Q2 (Standalone YoY)
Loss narrows to Rs 90.9 crore Vs loss of Rs 138.7 crore
Revenue soars 7.5% to Rs 1,491.8 crore Vs Rs 1,387.4 crore
Gujarat Pipavav Port Q2 (Consolidated YoY)
Profit zooms 112.9% to Rs 160.7 crore Vs Rs 75.5 crore
Revenue grows 31.8% to Rs 299.4 crore Vs Rs 227 crore
Garden Reach Shipbuilders & Engineers Q2 (Consolidated YoY)
Profit spikes 57.3% to Rs 153.8 crore Vs Rs 97.8 crore
Revenue surges 45.5% to Rs 1,677.4 crore Vs Rs 1,152.9 crore
Stocks to Watch
Mahindra and Mahindra is likely to sell its entire 3.45% stake in the bank, with the block size likely at $78 million (Rs 682 crore) and a floor price of Rs 317 per share, reports CNBC-TV18 quoting sources.
The IT services, consulting, and business solutions company has expanded its 18-year partnership with ABB to modernize ABB’s global hosting operations, simplify its IT landscape, and strengthen its digital foundation to drive resilience and innovation.
The company has signed an agreement with RSWM for the supply of 60 MW of renewable energy to RSWM’s multiple plant locations. RSWM invested Rs 60 crore under the Group Captive Scheme with a renewable generation company (genco) for the supply of 31.53 crore units of green power per annum to its manufacturing facilities across Rajasthan. With this addition, the contribution of renewable energy in RSWM’s total energy requirement will rise from the current 33% to 70% in the near future (two-thirds of its total energy mix).
The company has received an Establishment Inspection Report (EIR) from the USFDA (US Food and Drug Administration) for its manufacturing facility in SEZ II, Ahmedabad.
The USFDA conducted an inspection at the group’s manufacturing plant during August 11-14, 2025. The inspection was a Pre-Approval Inspection (PAI). The USFDA has concluded this inspection as closed, with no observations. The EIR has classified the facility as No Action Indicated (NAI).
The company's wholly owned subsidiary, Relonchem in the UK, has received marketing authorization for its product Exemestane 25mg film-coated tablets from the UK MHRA. Exemestane tablets are used to treat hormone-positive breast cancer in postmenopausal women.
The company reported total sales of 2,835 units in the month of October, growing 32.1% compared to 2,146 units sold in the same month last year.
Gujarat Narmada Valley Fertilizers and Chemicals Company
The Board has approved the appointment of Manoj Kumar Das, IAS, as Director and Chairman of the company.
Bulk Deals
Stallion India Fluorochemicals
Promoter Shazad Sheriar Rustomji sold 8.08 lakh shares (equivalent to 1.01% of paid-up equity) in Stallion India at Rs 247.65 per share, valued at Rs 20.01 crore. The total promoters' shareholding in the company was 67.9 percent as of September 2025.
However, Savita Jayesh Shah acquired 4.04 lakh shares (0.5% stake), and Jayeshbhai Nagindas Shah bought 4.04 lakh shares (0.5% stake) in Stallion India at Rs 247.65 per share.
Promoter Anjay Ratanlal Agarwal sold 1 lakh shares in the information technology and cyber security auditing and consulting company at Rs 93.1 per share for a total of Rs 93.1 lakh to Nautilus.
Mainboard Listing
Orkla India
SME Listing
Safecure Services
Stocks Trade Ex-Dividend
Hindustan Petroleum Corporation
Nippon Life India Asset Management
Share India Securities
TD Power Systems
Vaibhav Global
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
